Emergence of Acquired Dolutegravir Resistance in Treatment-experienced People With HIV in Lesotho
Clinical Infectious Diseases · 2024
DOI: 10.1093/cid/ciae185 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2024. Verfasst von Nadine Tschumi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Epidemiology, Department of Clinical Research, University Hospital Basel, Basel, Switzerland. Hauptthemen laut MEDLINE: Pyridones, Oxazines, Heterocyclic Compounds, 3-Ring, HIV Infections. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss National Science Foundation, University of Basel, Fondation Botnar.
Abstract (Originalsprache)
Background
Since 2019, the World Health Organization has recommended dolutegravir-based antiretroviral therapy (ART) as the preferred regimen for human immunodeficiency virus management. Large-scale programmatic transitioning to dolutegravir-based ART was subsequently implemented across Africa, often in the absence of recent viral load testing and without access to genotypic resistance testing (GRT) in case of viremia.
Methods
This study assessed emerging dolutegravir resistance in the routine care of the Viral Load Cohort North-East Lesotho. We included pediatric and adult participants who changed from nonnucleoside reverse transcriptase inhibitor– to dolutegravir-based ART and had at least 1 viral load assessment before and after the change. We sequenced available samples of participants fulfilling the additional virological criteria of having 2 viremic episodes while taking dolutegravir, with at least 1 viral load ≥500 copies/mL taken ≥18 months after changing to dolutegravir.
Results
Among 15 349 participants, 157 (1.0%) met the virological criteria, and GRT was successful for 85 (0.6%). Among these 85, 8 (9.4%) had dolutegravir resistance, with 2 (2.4%) and 6 (7.1%) predicted to have intermediate- and high-level dolutegravir resistance, respectively. One participant had 2, 2 had 1, and 5 had 0 active drugs in their regimen. A GRT from before the change to dolutegravir was available for 5 of these 8 participants: 4 had 0 and 1 had 1 active drug in their nonnucleoside transcriptase inhibitor–based regimen.
Conclusions
Nine percent of people with persistent or recurring human immunodeficiency virus viremia ≥18 months after changing to dolutegravir-based ART had dolutegravir resistance. Detection and management of emerging dolutegravir resistance must be addressed across Africa.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Clinical Epidemiology, Department of Clinical Research, University Hospital Basel, Basel, Switzerland.
- Department of Clinical Research, University of Basel, Basel, Switzerland.
- SolidarMed, Partnerships for Health, Maseru, Lesotho.
- Clinical Virology, Laboratory Medicine, University Hospital Basel, Switzerland.
ORCID-Profile: Nadine Tschumi, Blaise Lukau, Katleho Tlali, Kathrin Haenggi, Klaudia Naegele, Irene Ayakaka, Karoline Leuzinger, Jennifer A Brown, Niklaus D Labhardt
Förderung
- Swiss National Science Foundation
- University of Basel
- Fondation Botnar
Zitieren
APA
Tschumi, N., Lukau, B., Tlali, K., Motaboli, L., Kao, M., Kopo, M., Haenggi, K., Mokebe, M., Naegele, K., Ayakaka, I., Leuzinger, K., Brown, J. A., & Labhardt, N. D. (2024). Emergence of Acquired Dolutegravir Resistance in Treatment-experienced People With HIV in Lesotho. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciae185
Vancouver
Tschumi N, Lukau B, Tlali K, Motaboli L, Kao M, Kopo M, et al. Emergence of Acquired Dolutegravir Resistance in Treatment-experienced People With HIV in Lesotho. Clinical Infectious Diseases. 2024. doi:10.1093/cid/ciae185
BibTeX
@article{Tschumi2024,
author = {Tschumi, Nadine and Lukau, Blaise and Tlali, Katleho and Motaboli, Lipontso and Kao, Mpho and Kopo, Mathebe and Haenggi, Kathrin and Mokebe, Moleboheng and Naegele, Klaudia and Ayakaka, Irene and Leuzinger, Karoline and Brown, Jennifer A and Labhardt, Niklaus D},
title = {Emergence of Acquired Dolutegravir Resistance in Treatment-experienced People With HIV in Lesotho},
journal = {Clinical Infectious Diseases},
year = {2024},
doi = {10.1093/cid/ciae185}
}
EUVIMED